MedTrace Logo

Platelet-rich Plasma for Thumb Carpometacarpal Joint Osteoarthritis

NCT04886349 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2021-05-14

No results posted yet for this study

Summary

The purpose of this study is to investigate a case series of patients treated with Platelet-rich plasma for thumb carpometacarpal joint osteoarthritis. Carpometacarpal arthritis is a highly prevalent condition with significant effects on quality of life and function. Meanwhile, platelet-rich plasma has been demonstrated to be an effective treatment for various musculoskeletal conditions.

Conditions

  • Thumb Carpometacarpal Joint Osteoarthritis

Interventions

BIOLOGICAL

Platelet-rich plasma

Platelet-rich plasma injection for first CMC OA

Sponsors & Collaborators

Principal Investigators

  • Jeffrey Brault, D.O. · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-04-01
Completion
2021-04-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04886349 on ClinicalTrials.gov